[EW] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[EW] Edwards Lifesciences Corporation
Announcement Date
28-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -15.48%
YoY- 1.00%
Quarter Report
EW's Result
EW's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 1,354,400 1,480,900 1,319,000 1,310,200 1,140,900 1,094,000 906,600 6.91%
PBT 402,800 439,300 407,300 390,900 364,300 301,700 248,700 8.36%
Tax 40,700 55,600 63,800 50,800 39,100 27,000 22,800 10.12%
NP 3,070,800 384,900 343,500 340,100 325,200 274,700 225,900 54.42%
Tax Rate -10.10% -12.66% -15.66% -13.00% -10.73% -8.95% -9.17% -
Total Cost -1,716,400 1,096,000 975,500 970,100 815,700 819,300 680,700 -
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 226.73 25.99 26.04 25.96 28.50 25.11 24.92 44.43%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 5.14 0.63 0.55 0.55 0.52 0.44 0.36 55.69%
EPS Diluted 5.13 0.63 0.55 0.54 0.52 0.43 0.35 56.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.